This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Sanford-Burnham Medical Research Institute, Southern Research Institute. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015
Title: The Innovations of Nicholas Pagano
Introduction
Nicholas Pagano is a notable inventor based in La Jolla, California. He has made significant contributions to the field of medical research, particularly in the development of HIV replication inhibitors. His work has the potential to impact the treatment and management of HIV, showcasing his dedication to advancing healthcare.
Latest Patents
Nicholas Pagano holds a patent for HIV replication inhibitors, specifically for compounds of Formula (I) wherein B is selected from the group consisting of substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl. The patent also details that Y is a linker moiety selected from the group consisting of a direct bond, while R, R1, R2, and R3 are each individually selected from the group consisting of substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or heterocycle. This patent represents his innovative approach to combating HIV.
Career Highlights
Throughout his career, Nicholas Pagano has worked with esteemed organizations such as Southern Research Institute and Sanford-Burnham Medical Research Institute. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Marintha L. Heil and Nicholas D. P. Cosford. Their collaborative efforts have furthered the research and development of innovative solutions in the medical field.
Conclusion
Nicholas Pagano's contributions to the field of HIV research through his patent and collaborations highlight his commitment to innovation in healthcare. His work continues to inspire advancements that may lead to improved treatments for those affected by HIV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile